Erleada - Drug Insight, 2019

Erleada - Drug Insight, 2019 report provides comprehensive information of the drug, Erleada. It includes drugs overview, Erleada mechanism of action, clinical trials, regulatory milestones, deals & Erleada's partnerships. It further provides Erleada`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted Erleada sales till 2021. The report also throws light on Erleada market competition and emerging therapies in the same space as Erleada. Erleada SWOT analysis is also featured. * Depending on information availability.

Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by the research team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report

• A comprehensive Erleada overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
• Erleada Patent information in United States (US) and Europe (EU) has been highlighted
• Erleada API manufacturers in United States, Europe, China and India
• The report contains historical and forecasted Erleada sales till 2021
• Comprehensive coverage of the emerging therapies (Phase III) in the space where Erleada operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
• The report also features the Erleada SWOT analysis

Reasons to Buy

• Establish a comprehensive understanding of the drug, Erleada
• Access to Erleada API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around Erleada patents for the major markets- US and EU
• Understand current and future Erleada`s growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for Erleada
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as Erleada
• Identify opportunities in the same area as with Erleada SWOT analysis